Does Zinc Supplementation Increase the Risk of Prostate Cancer? | Nutrition | JAMA Ophthalmology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.239.150.57. Please contact the publisher to request reinstatement.
1.
Briefel  RRBialostosky  KKennedy-Stephenson  JMcDowell  MAErvin  RBWright  JD Zinc intake of the US population: findings from the Third National Health and Nutrition Examination Survey, 1988-1994.  J Nutr 2000;1301367S- 1373SPubMedGoogle Scholar
2.
Liang  JYLiu  YYZou  JFranklin  RBCostello  LCFeng  P Inhibitory effect of zinc on human prostatic carcinoma cell growth.  Prostate 1999;40200- 207PubMedGoogle ScholarCrossref
3.
Uzzo  RGLeavis  PHatch  W  et al.  Zinc inhibits nuclear factor-kappa B activation and sensitizes prostate cancer cells to cytotoxic agents.  Clin Cancer Res 2002;83579- 3583PubMedGoogle Scholar
4.
Brys  MNawrocka  ADMiekos  E  et al.  Zinc and cadmium analysis in human prostate neoplasms.  Biol Trace Elem Res 1997;59145- 152PubMedGoogle ScholarCrossref
5.
Zaichick  VYSviridova  TVZaichick  SV Zinc in the human prostate gland: normal, hyperplastic and cancerous.  Int Urol Nephrol 1997;29565- 574PubMedGoogle ScholarCrossref
6.
Henshall  SMAfar  DERasiah  KK  et al.  Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer.  Oncogene 2003;226005- 6012PubMedGoogle ScholarCrossref
7.
Rishi  IBaidouri  HAbbasi  JA  et al.  Prostate cancer in African American men is associated with downregulation of zinc transporters.  Appl Immunohistochem Mol Morphol 2003;11253- 260PubMedGoogle ScholarCrossref
8.
Whelan  PWalker  BEKelleher  J Zinc, vitamin A and prostatic cancer.  Br J Urol 1983;55525- 528PubMedGoogle ScholarCrossref
9.
Ogunlewe  JOOsegbe  DN Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate.  Cancer 1989;631388- 1392PubMedGoogle ScholarCrossref
10.
Feustel  AWennrich  RSchmidt  B Serum-Zn-levels in prostatic cancer.  Urol Res 1989;1741- 42PubMedGoogle Scholar
11.
Habib  FKDembinski  TCStitch  SR The zinc and copper content of blood leucocytes and plasma from patients with benign and malignant prostates.  Clin Chim Acta 1980;104329- 335PubMedGoogle ScholarCrossref
12.
Kristal  ARStanford  JLCohen  JHWicklund  KPatterson  RE Vitamin and mineral supplement use is associated with reduced risk of prostate cancer.  Cancer Epidemiol Biomarkers Prev 1999;8887- 892PubMedGoogle Scholar
13.
Key  TJSilcocks  PBDavey  GKAppleby  PNBishop  DT A case-control study of diet and prostate cancer.  Br J Cancer 1997;76678- 687PubMedGoogle ScholarCrossref
14.
Platz  EAHelzlsouer  KJHoffman  SCMorris  JSBaskett  CKComstock  GW Prediagnostic toenail cadmium and zinc and subsequent prostate cancer risk.  Prostate 2002;52288- 296PubMedGoogle ScholarCrossref
15.
Leitzmann  MFStampfer  MJWu  KColditz  GAWillett  WCGiovannucci  EL Zinc supplement use and risk of prostate cancer.  J Natl Cancer Inst 2003;951004- 1007PubMedGoogle ScholarCrossref
16.
Chandra  RK Excessive intake of zinc impairs immune responses.  JAMA 1984;2521443- 1446PubMedGoogle ScholarCrossref
17.
Holmes  MDPollak  MNHankinson  SE Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations.  Cancer Epidemiol Biomarkers Prev 2002;11862- 867PubMedGoogle Scholar
18.
Age-Related Eye Disease Study Research Group, A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report No. 8.  Arch Ophthalmol 2001;1191417- 1436PubMedGoogle ScholarCrossref
Special Article
January 1, 2005

Does Zinc Supplementation Increase the Risk of Prostate Cancer?

Author Affiliations

Author Affiliations: Department of Surgery, Division of Urology, and Environmental and Molecular Toxicology, University of Wisconsin, Madison.

Arch Ophthalmol. 2005;123(1):102-103. doi:10.1001/archopht.123.1.102

In the United States, prostate cancer is the most commonly diagnosed cancer in men and the second leading cause of cancer deaths in this population. It is estimated that 220 000 cases of prostate cancer will be diagnosed this year, and this is expected to increase with the expanding geriatric population. The etiology of prostate cancer is multifactorial. Genetic factors are important and contribute to incidence rates that are higher in African Americans than any other racial group. It is also clear that diet plays an important role in modulating the cancer phenotype. There is expanding interest, both in the lay press and the scientific community, in the use of dietary supplements that minimize the initiation and progression of prostate cancer.

×